What Does Diasorin Do?

Total employees2414
HeadquartersSaluggia
Founded

DiaSorin S.p.A. is an Italian multinational biotechnology company focused on improving health and science through the development, production, and commercialization of diagnostic tests. Specializing in immunodiagnostics and molecular diagnostics, DiaSorin offers a broad range of solutions for infectious diseases, endocrinology, oncology, autoimmune disorders, and other clinical areas. The company is committed to innovation, providing high-quality and reliable diagnostic tools to clinical laboratories, hospitals, and research institutions globally, thereby contributing to enhanced patient care and public health.

Where Is Diasorin's Headquarters?

HQ Function

The Saluggia headquarters is the nerve center for DiaSorin's global operations, housing corporate management, core research and development activities, strategic manufacturing for key product lines, and global marketing strategy.

Notable Features:

The Saluggia campus is a significant industrial site featuring advanced research laboratories, automated manufacturing facilities, and logistics hubs. It's part of a region with a strong heritage in scientific and technological innovation.

Work Culture:

DiaSorin's headquarters fosters a work culture centered on scientific excellence, innovation, quality, and collaboration. Employees are driven by the mission to improve healthcare outcomes, working in a dynamic and international environment.

HQ Significance:

The Saluggia headquarters is crucial for DiaSorin's strategic direction, product innovation pipeline, and global manufacturing network. It symbolizes the company's Italian roots and its evolution into a global leader in diagnostics.

Values Reflected in HQ: The headquarters reflects DiaSorin's core values of innovation, commitment to quality, scientific rigor, and a global vision for advancing healthcare through diagnostics.

Location:

DiaSorin has established a robust global presence, operating directly in major European countries, North America, South America, China, India, Australia, and other key Asia-Pacific markets. Its worldwide functions include a network of research and development centers, multiple manufacturing sites ensuring global supply, extensive sales and marketing operations, efficient distribution channels, and comprehensive technical and customer support. This expansive network allows DiaSorin to deliver its diagnostic solutions to laboratories, hospitals, and healthcare providers in over 100 countries.

Street Address:

Via Crescentino snc

City:

Saluggia

State/Province:

VC (Vercelli)

Country:

Italy

Where Else Does Diasorin Operate Around the World?

Stillwater, Minnesota/USA

Address: 1951 Northwestern Ave, Stillwater, MN 55082

To cater to the extensive North American diagnostic market, drive innovation in immunodiagnostics, ensure product supply, and provide localized technical and commercial support to customers in the region.

Carlsbad, California/USA

Address: 5781 Van Allen Way, Carlsbad, CA 92008

To expand DiaSorin's footprint in the molecular diagnostics sector, leverage Californian biotech expertise, and address the growing global and U.S. demand for advanced molecular testing solutions.

Dietzenbach/Germany

Address: Adam-Opel-Straße 2-4, 63322 Dietzenbach

To serve the important German healthcare market effectively, provide direct support to local customers, and manage regional commercial strategies for DiaSorin's diagnostic portfolio.

Buying Intent Signals for Diasorin

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Diasorin? Meet the Executive Team

As of April 2025, Diasorin' leadership includes:

Carlo Rosa - Group Chief Executive Officer (CEO)
Piergiorgio Pedron - Group Chief Financial Officer (CFO)
Ugo Gay - Group Chief Operating Officer (COO)
Chen Menachem Even - Group Chief Commercial Officer (CCO)
Stefano Ronchi - Corporate Senior Vice President Business Development, Licensing & Acquisition
Francesca Sagramoso - Corporate Senior Vice President Human Resources & Organization
David Nemargut - Corporate Senior Vice President Molecular Global Business Unit & North America CEO

Who's Investing in Diasorin?

Diasorin has been backed by several prominent investors over the years, including:

Finde S.S. (primary and reference shareholder, representing the Denegri family interests)
DiaSorin is publicly traded on Euronext Milan (DIA.MI), part of the FTSE MIB index, with shares held by various institutional and retail investors globally.

What Leadership Changes Has Diasorin Seen Recently?

Hire0
Exits0

DiaSorin's core C-suite executive team has maintained stability over the past 12 months (ending May 2024). In April 2024, the Shareholders' Meeting appointed a new Board of Directors for the 2024-2026 term. Subsequently, in May 2024, the Board of Directors confirmed Carlo Rosa as Chief Executive Officer and assigned executive powers. No other major C-level operational executive hires or departures have been prominently announced during this period.

New Appointments:

Carlo Rosa, Carlo Rosa was re-confirmed as Chief Executive Officer by the newly appointed Board of Directors.

What Technology (Tech Stack) Is Used byDiasorin?

Discover the tools Diasorin uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Diasorin Email Formats and Examples

DiaSorin commonly utilizes the 'first.last' email format for its employees globally. While minor variations or legacy formats might exist within specific departments or regions, 'first.last@diasorin.com' is the predominant structure for professional communication.

first.last@diasorin.com

Format

carlo.rosa@diasorin.com

Example

85%

Success rate

What's the Latest News About Diasorin?

DiaSorin Official WebsiteMay 7, 2024

DiaSorin: Board of Directors Approves Q1 2024 Results, Revenues at €289 million

DiaSorin's Board of Directors approved the Q1 2024 consolidated financial results, with revenues reaching €289 million. The company highlighted positive performance in its ex-COVID product lines across immunodiagnostics and molecular diagnostics, and confirmed its financial guidance for the full year 2024....more

DiaSorin Official WebsiteApril 23, 2024

DiaSorin: Shareholders' Meeting Appoints New Board of Directors and Approves 2023 Financial Statements

The Shareholders' Meeting of DiaSorin S.p.A. approved the financial statements for the year ended December 31, 2023. Additionally, the meeting appointed the new Board of Directors and Board of Statutory Auditors for the three-year period 2024-2026. Michele Denegri was confirmed as Chairman of the Board....more

DiaSorin Official WebsiteMarch 12, 2024

DiaSorin Launches New LIAISON® Verotox Assay for Enhanced Detection of Shiga Toxin-Producing E.coli (STEC)

DiaSorin announced the commercial launch of its LIAISON® Verotox test, a chemiluminescent immunoassay (CLIA) designed for the qualitative detection of Verotoxin 1 (VT1) and Verotoxin 2 (VT2) in human stool specimens. This new assay aims to improve diagnostic capabilities for Shiga toxin-producing E. coli (STEC) infections....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Diasorin, are just a search away.